
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
Keywords: سرطان کبد; Cancer Immunotherapy; Tumor-Associated Antigens; Liver Cancer; Immune Response; E:T; effector to target cell ratio; GPC3; glypican-3; HCC; hepatocellular carcinoma; HLA; human leukocyte antigen; hTCM; human T-cell medium; IFN; interferon; IL; interleukin;